| 2025-10-22 | Ms. Michelle Nicole JablkoCEO, MD & Director | 217,82k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-08-29 | Ms. Michelle Nicole JablkoCEO, MD & Director | -19,32k | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-08-29 | Ms. Michelle Nicole JablkoCEO, MD & Director | 25,61k | 0,00 | Derivative Exercise and Retained Stock | - | 171,78k | 17,52% |
| 2025-08-22 | Ms. Michelle Nicole JablkoCEO, MD & Director | 47,25k | 0,00 | Derivative Exercise and Retained Stock | - | 146,17k | 47,77% |
| 2024-12-23 | BlackRock, Inc.Unternehmen | 48,33M | 0,00 | Kauf | 8,16 - 9,45 | 315,32M | 18,10% |
| 2024-12-23 | BlackRock, Inc.Unternehmen | -27,58M | 97,38k | Verkauf | 8,18 - 9,48 | 315,32M | -8,04% |
| 2024-12-27 | BlackRock, Inc.Unternehmen | -46,76M | 0,00 | Other Disposition | - | 315,32M | -12,92% |
| 2024-12-26 | Aperio Group, LLCUnternehmen | -3,93M | 0,00 | Other Disposition | - | 1,05M | -78,96% |
| 2025-06-24 | Dr. Sarah Elizabeth RyanIndependent Non-executive Director | 1.000,00 | 9,44k | Kauf | 9,44 | 6,00k | 20,00% |